688079 Hangzhou MDK Opto Electronics co.,Ltd
- 7.78
- -0.01-0.13%
Hangzhou MDK Opto Electronics co.,Ltd News
Medikai (688079.SH): The company did not repurchase shares in May.
On May 2024, MediKai (688079.SH) announced not to repurchase shares. As of May 31, 2024, the company repurchased 406,392 shares through the Shanghai Stock Exchange trading system in a centralized bidding manner, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest repurchase price was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount paid was RMB 4,207,826.96 (excluding stamp duty, trading commissions, and other transaction costs).
Medicare (688079.SH): The company successfully developed the TGV process
Gelonghui, May 22丨Mediq (688079.SH) said on the investor interactive platform that the company has successfully developed the TGV process (glass through-hole process) to treat glass substrates with tiny holes (min10μm) through holes and blind holes through laser-induced and wet corrosion processes.
Medicare (688079.SH): Repurchase 406,400 shares as of April 30
Gelonghui (688079.SH) announced on May 6, 2024, that as of April 30, 2024, the company had repurchased 406,392 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
Medicai (688079.SH): Net loss of 235.59 million yuan in the first quarter
On April 28, Ge Longhui (688079.SH) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 116 million yuan, an increase of 22.30% over the previous year. Achieved a net loss of 235.59 million yuan attributable to shareholders of listed companies. Achieved a net loss of RMB 18.0883 million attributable to shareholders of the listed company after deducting non-recurring profit and loss.
Medicare (688079.SH) reported 2023 results, with a net loss of 84.4509 million yuan, which changed from profit to loss over the previous year
Medicare (688079.SH) released its 2023 annual report, achieving operating revenue of 321 million yuan, compared with...
Medicare (688079.SH): First quarter report will be disclosed on April 29th
On April 15, GLONGHUI (688079.SH) said on the investor interactive platform that according to the work schedule, the company's report for the first quarter of 2024 will be disclosed on April 29, 2024.
Medicare (688079.SH): Repurchase 406,400 shares as of March 31
Gelonghui, April 2, 丨 Medicai (688079.SH) announced that as of March 31, 2024, the company had repurchased 406,392.00 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
Medicare (688079.SH): The image sensor wafer optical path system project in collaboration with the customer has now begun small-batch production
Gelonghui, March 26 | Mediq (688079.SH) said on the investor interactive platform that the company's cooperative image sensor (CIS) wafer optical path system project with customers has now begun small-batch production, and it is gradually increasing every month. Subject to confidentiality agreements, the company is unable to disclose the details of cooperation with specific customers.
Medicare (688079.SH): Revenue from the optical semiconductor business is gradually recovering and growing
On March 14, GLONGHUI (688079.SH) said on the investor interactive platform that with the gradual recovery of downstream demand, the company's optical semiconductor business revenue is gradually recovering and growing.
There's Reason For Concern Over Hangzhou Mdk Opto Electronics Co.,Ltd's (SHSE:688079) Massive 35% Price Jump
Those holding Hangzhou Mdk Opto Electronics Co.,Ltd (SHSE:688079) shares would be relieved that the share price has rebounded 35% in the last thirty days, but it needs to keep going to repair the rece
The storage giant plans to use nano-printing technology, and local manufacturers are expected to face overtaking opportunities at bends
① According to reports, Micron Technology plans to take the lead in supporting Canon's nano-printing technology to further reduce the cost of producing a single layer of DRAM memory chips. ② According to TechnaVio data, the nanoimprinting market is expected to reach 3.3 billion US dollars in 2026, with a compound growth rate of 17.74% from 2021 to 2026.
Private Equity Firms Among Hangzhou Mdk Opto Electronics Co.,Ltd's (SHSE:688079) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 12% Last Week
Key Insights The considerable ownership by private equity firms in Hangzhou Mdk Opto ElectronicsLtd indicates that they collectively have a greater say in management and business strategy 51% of the
Medicare (688079.SH): Repurchase 406,400 shares as of February 29
Gelonghui (688079.SH) announced on March 1, 2024, that as of February 29, 2024, the company had repurchased 406,392.00 shares through the Shanghai Stock Exchange trading system, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
A-shares, MR headlining concept stocks strengthened, and Medikay rose more than 13%
Gronghui, March 1 | Medicare rose more than 13%, 100 million channels of information rose and stopped, and Jingyan Technology and Chinese online followed suit.
Medicare (688079.SH): Shareholder Holding Group increased its holdings by a total of 1.054 million shares
Gelonghui, Feb. 28 | Medikai (688079.SH) announced that as of February 28, 2024, the company's shareholder holding group had increased its holdings by 1.054 million shares through centralized bidding transactions in the secondary market through the Shanghai Stock Exchange system, accounting for 0.25% of the company's total share capital, with a total increase of 10.4721 million yuan. It has exceeded the lower limit of the amount of the current holdings increase plan, and the increase period has expired.
Mediq (688079.SH) Performance Report: Net loss of 82.9628 million yuan in 2023
Gelonghui, Feb. 23 | Medicai (688079.SH) announced the 2023 Annual Results Report. The company achieved operating income of 3210.9 million yuan in 2023, a year-on-year decrease of 22.41%, and realized net profit attributable to the owners of the parent company - 82.9628 million yuan, a year-on-year decrease of 475.58%. Net profit attributable to the owners of the parent company after deducting non-recurring gains and losses - 75.912,600 yuan, a year-on-year decrease of 452.15%.
Medicare (688079.SH): The ban on 223 million restricted shares was lifted on March 4
On February 22, GLONGHUI (688079.SH) announced that the total number of shares in circulation in the company's current stock listing is 223 million shares. The stock listing and circulation date is March 4, 2024 (since March 2, 2024 is a non-trading day, it was postponed to the next trading day).
Medicare (688079.SH): Repurchase 406,400 shares as of January 31
Gelonghui, Feb. 2 | Medikai (688079.SH) announced that as of January 31, 2024, the company had repurchased 406,392.00 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest price of the repurchase transaction was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96 (excluding transaction fees such as stamp duty and transaction fees).
Medicare (688079.SH) issued a forecast loss. The net loss is expected to be around RMB 806.63 million in 2023, changing from profit to loss over the previous year
Medicare (688079.SH) announced its 2023 annual results forecast and is expected to operate in 2023...
Medicare (688079.SH): The company did not repurchase shares in December
GLONGHUI January 2 丨 Medicai (688079.SH) announced that in December 2023, the company did not repurchase shares. As of December 31, 2023, the company repurchased 406,392.00 shares of the company through centralized bidding transactions, accounting for 0.10% of the company's total share capital of 401,333,334 shares. The highest repurchase transaction price was 11.38 yuan/share, the lowest price was 10.05 yuan/share, and the total amount of capital paid was RMB 4,207,826.96.
Analysis
Price Target
No Data
